China News Service, November 3 According to Malaysia’s Sin Chew Daily, the Ministry of Health of Malaysia stated on the 3rd that the two influenza vaccines SKYCellflu Quadrivalent and Vaxigrip Tetra from South Korea that had been stopped earlier can be resumed.
Malaysian Health Director Nohisan said that the National Pharmaceutical Control Group under the Ministry of Health has studied the risks of the above two vaccines in detail based on data from the Korean Disease Control and Prevention Agency, domestic and foreign safety reports and international control agencies.
"As of October 31, the Korean Agency for Disease and Prevention has confirmed that the chance of death from influenza vaccine is very low."
Earlier, the Malaysian Ministry of Health pointed out on October 28 that because the above-mentioned Korean vaccines were alleged to have caused multiple deaths, it advised medical staff to suspend the use of these vaccines.
Nuo Xishan said that according to the Korean Agency for Disease and Prevention, there is no specific vaccine brand, manufacturer or production number associated with the death case.
The Ministry of Health has assessed the quality of influenza vaccines and reports of local and international vaccination abnormal reactions, including the above two vaccines.
He pointed out that the 1.5 million vaccines introduced into Malaysia as of October have complied with the prescribed quality standards, including the two Korean vaccines.
The investigation also revealed that no one in Malaysia died after flu vaccine.
According to previous media reports, South Korea will expand its influenza vaccination program in 2020 and intend to provide free vaccination to approximately 19 million teenagers and elderly people.
On October 16, a 17-year-old teenager in Incheon City died after being vaccinated with influenza. Since then, similar cases in South Korea have continued to increase.
As of November 3 local time, a total of 88 people in South Korea have died after being vaccinated with influenza.